New Advanced Basal Cell Carcinoma Drug

1 Views
administrator
administrator
06/16/23

Aleksandar Sekulic, M.D., Ph.D., a dermatologist and cancer researcher at Mayo Clinic in Arizona, explains study results that show the drug Erivedge (vismodegib) shrank advanced basal cell carcinoma tumors in 43 percent of patients with locally advanced disease and in 30 percent of patients whose disease spread to other organs.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next